India Globalization Capital, Inc. (NYSE: IGC) Positioned to Lead in Phytocannabinoid Pharmaceuticals

From The QualityStocks Daily Blog for Micro-cap and Small-Cap Companies
May 8, 2017 - 12:54pm
A study recently highlighted by the American Epilepsy Society (AES) at its 70th annual meeting focused on the potential of cannabidiol (CBD), a derivative of the cannabis plant, as a promising treatment for reducing both the frequency and severity of seizures in children with drug resistant epilepsies (http://dtn.fm/4uYeH). According to the study, patients who received […]


Continue reading this article »